Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Protocols in Neuroscience
|
October 6, 2009
Imaging nervous system activity
Douglas R Fields, Neil Shneider, George Z Mentis, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 28, 2024
Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negatives
Ikjae Lee, Mark A Garret, Joanne Wuu, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis
Olivia M Rifai, Fergal M Waldron, Judi O'Shaughnessy, et al.
Developmental Cell
|
June 15, 2024
Identifying FUS amyotrophic lateral sclerosis disease signatures in patient dermal fibroblasts
Karl Kumbier, Maike Roth, Zizheng Li, et al.
Acta Neuropathologica
|
March 5, 2024
RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS
Holly Spence, Fergal M Waldron, Rebecca S Saleeb, et al.
Muscle & Nerve
|
September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis
James D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord
John F Tuddenham, Masashi Fujita, Anthony Khairallah, et al.
Science Advances
|
February 21, 2025
SUMO2/3 conjugation of TDP-43 protects against aggregation
Enza Maria Verde, Francesco Antoniani, Laura Mediani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis
Daisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Nature Reviews. Neurology
|
May 29, 2024
Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D Huey, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Protocols in Neuroscience
|
October 6, 2009
Imaging nervous system activity
Douglas R Fields, Neil Shneider, George Z Mentis, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 28, 2024
Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negatives
Ikjae Lee, Mark A Garret, Joanne Wuu, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis
Olivia M Rifai, Fergal M Waldron, Judi O'Shaughnessy, et al.
Developmental Cell
|
June 15, 2024
Identifying FUS amyotrophic lateral sclerosis disease signatures in patient dermal fibroblasts
Karl Kumbier, Maike Roth, Zizheng Li, et al.
Acta Neuropathologica
|
March 5, 2024
RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS
Holly Spence, Fergal M Waldron, Rebecca S Saleeb, et al.
Muscle & Nerve
|
September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis
James D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord
John F Tuddenham, Masashi Fujita, Anthony Khairallah, et al.
Science Advances
|
February 21, 2025
SUMO2/3 conjugation of TDP-43 protects against aggregation
Enza Maria Verde, Francesco Antoniani, Laura Mediani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis
Daisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Nature Reviews. Neurology
|
May 29, 2024
Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D Huey, et al.
Page
of 2